Covance Executive Leadership

At Covance, we understand the complexity of the drug development process and the challenges you face. As your proactive partner, we’ll identify hurdles and address strategic approaches to evolve with your project. Together, we can achieve your milestones and help set you up for success. 

Our Executive Leadership team is committed to delivering innovative solutions that transform scientific possibilities into realities. Having helped develop one-third of all prescription medicines in the market today, we have proven ability to help deliver Solutions Made Real®.

Deborah Keller - Executive Vice President, Covance and Group President, R&D Laboratories

Deborah Keller
Chief Executive Officer

Steven Anderson, PhD - Chief Scientific Officer (CSO)

Steven Anderson
Chief Scientific Officer

Dr. Dimitris K. Agrafiotis, Ph.D., FRSC - Vice President and Chief Data Officer, Covance

Dimitris Agrafiotis
Chief Data Officer

Honggang Bi - General Manager, China

Honggang Bi
General Manager, China

Jared Freedberg - Vice President, Business Development and Strategy

Jared Freedberg
Business Development and Strategy

Chris Gegelys - General Counsel

Chris Gegelys
General Counsel

John Gransee, M.B.A., C.P.A. - Chief Financial Officer, Covance

John Gransee
Chief Financial Officer

Jonathan Koch - Group President, R&D Laboratories

Jonathan Koch
Group President, R&D Laboratories

Jean-Marc Leroux - Vice President, Global Innovation and Business Development for R&D Labs, General Manager CCLS Europe

Jean-Marc Leroux
Chief Innovation Officer

Vicki Neddenriep - Vice President, Global HR Partnering

Vicki Neddenriep
Global HR Partnering

Nicole O'Rourke - Chief Marketing Officer

Nicole O'Rourke
Chief Marketing Officer

Ken Somberg - Chief Medical Officer

Ken Somberg
Chief Medical Officer